478
Participants
Start Date
June 30, 2016
Primary Completion Date
May 31, 2019
Study Completion Date
June 30, 2019
Embolic Protection Device
Embolic protection
Transcatheter aortic valve implantation (TAVI)
Transcatheter aortic valve implantation (TAVI)
New York University, New York
Columbia University Medical Center/NYPH, New York
St. Francis Hospital, Roslyn
Pinnacle Health, Harrisburg
University of Pennsylvania, Philadelphia
MedStar Washington Hospital Center, Washington D.C.
University of Virginia, Charlottesville
Piedmont Hospital, Atlanta
Delray Medical Center, Hialeah
Morton Plant Hospital, Clearwater
Cleveland Clinic, Cleveland
University of Iowa, Iowa City
Northwestern University, Evanston
Cardiovascular Institute of the South, Houma
Baylor Research Center, Plano
Baylor Heart and Vascular HospitalBaylor Heart and Vascular, Dallas
Houston Methodist Hospital, Houston
University of Texas, Houston
Cedars-Sinai Medical Center, Los Angeles
Foundation for Cardiovascular Medicine, San Diego
Swedish Medical Center, Seattle
Yale New Haven Hospital, New Haven
Morristown Medical Center, Morristown
University of Bonn, Bonn
Universitats-Herzzentrum Freiburg, Freiburg im Breisgau
Hamburg Univeristy Cardiovascular Center, Hamburg
Leipzig Heart Institute, Leipzig
San Donato Hospital, Milan
San Rafeele Hospital, Milan
UMC Utrecht, Utrecht
Lead Sponsor
Keystone Heart
INDUSTRY